Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dietary Treatment of Glucose Transporter Type 1 Deficiency (G1D)

Trial Profile

Dietary Treatment of Glucose Transporter Type 1 Deficiency (G1D)

Phase of Trial: Phase II

Latest Information Update: 02 Jul 2018

At a glance

  • Drugs Triheptanoin (Primary)
  • Indications De Vivo disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jun 2018 Status changed from not yet recruiting to recruiting.
    • 12 Mar 2018 Planned End Date changed from 30 Nov 2022 to 30 May 2023.
    • 12 Mar 2018 Planned primary completion date changed from 30 Nov 2019 to 30 May 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top